share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  2024/11/19 05:35

Moomoo AI 已提取核心訊息

Cardio Diagnostics held its annual meeting on November 15, 2024, with 55.51% of eligible shares represented. Shareholders approved all four key proposals, including the election of seven directors and a significant reverse stock split authorization.Notably, stockholders approved an amendment allowing for a reverse stock split ratio between 1-for-5 and 1-for-40, to be implemented at the Board's discretion within one year. The meeting also approved the potential issuance of 20% or more of common stock in non-public transactions under Nasdaq Rule 5635(d), and ratified Prager Metis CPA's LLC as the independent auditor for FY2024.All seven director nominees were successfully elected, including Dr. Meeshanthini Dogan and Dr. Robert Philibert, with Paul F. Burton receiving the highest number of favorable votes at 7,466,218, while Dr. Warren Hosseinion received the most withheld votes at 1,885,711.
Cardio Diagnostics held its annual meeting on November 15, 2024, with 55.51% of eligible shares represented. Shareholders approved all four key proposals, including the election of seven directors and a significant reverse stock split authorization.Notably, stockholders approved an amendment allowing for a reverse stock split ratio between 1-for-5 and 1-for-40, to be implemented at the Board's discretion within one year. The meeting also approved the potential issuance of 20% or more of common stock in non-public transactions under Nasdaq Rule 5635(d), and ratified Prager Metis CPA's LLC as the independent auditor for FY2024.All seven director nominees were successfully elected, including Dr. Meeshanthini Dogan and Dr. Robert Philibert, with Paul F. Burton receiving the highest number of favorable votes at 7,466,218, while Dr. Warren Hosseinion received the most withheld votes at 1,885,711.
心血管診斷公司於2024年11月15日舉行年會，55.51%的符合資格的股份出席。股東批准了四項關鍵提案，包括選舉七名董事和一項重要的反向股票拆分授權。值得注意的是，股東批准了一項修正案，允許反向股票拆分比例在1比5至1比40之間，由董事會在一年內自行決定實施。會議還批准了根據納斯達克規則5635(d)進行非公開交易時發行20%或更多普通股的潛在計劃，並確認Prager Metis CPA's LLC爲2024財年的獨立核數師。所有七名董事候選人成功當選，包括Dr. Meeshanthini Dogan和Dr. Robert Philibert，Paul F. Burton獲得了7466218票的最高贊成票，而Dr. Warren Hosseinion獲得了1885711票的最高反對票。
心血管診斷公司於2024年11月15日舉行年會，55.51%的符合資格的股份出席。股東批准了四項關鍵提案，包括選舉七名董事和一項重要的反向股票拆分授權。值得注意的是，股東批准了一項修正案，允許反向股票拆分比例在1比5至1比40之間，由董事會在一年內自行決定實施。會議還批准了根據納斯達克規則5635(d)進行非公開交易時發行20%或更多普通股的潛在計劃，並確認Prager Metis CPA's LLC爲2024財年的獨立核數師。所有七名董事候選人成功當選，包括Dr. Meeshanthini Dogan和Dr. Robert Philibert，Paul F. Burton獲得了7466218票的最高贊成票，而Dr. Warren Hosseinion獲得了1885711票的最高反對票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Channel Therapeutics
    CHRO
    -- 1.900
    泰坦製藥
    TTNP
    -- 3.8350
    LakeShore Biopharma
    LSB
    -- 2.723
    Rigel Pharmaceuticals
    RIGL
    -- 20.130
    Veru Inc
    VERU
    -- 0.975

    解鎖榜首股票

    熱門討論
    特朗普2.0時代開啓，全球股市新風口在哪裏？
    ▪️加密貨幣政策能否利好crypto? ▪️關稅政策能否利好中概等海外資產？ ▪️在特朗普政策下，有哪些投資機會值得關注？ 展开
    離川普上臺只有7天了～